Physician profile
James E Francesconi
NPI 1326209800
$19,167.27
in general payments reported to CMS, 2019-2025
65 companies · $4,728 in 2025
The $4,728 reported for 2025 was more than what 84% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $286 · 2021: $1,652 · 2022: $3,511 · 2023: $4,741 · 2024: $4,012 · 2025: $4,728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,369.00 |
| Education | $111.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,572.27 | 2021-2025 | |
| Pfizer INC. | $1,562.39 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,081.00 | 2021-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Lundbeck LLC | $1,020.45 | 2021-2025 | Vyepti, Rexulti |
| Impel Pharmaceuticals INC. | $985.19 | 2022-2023 | Trudhesa |
| Emd Serono, INC. | $925.66 | 2021-2025 | Mavenclad, Mavenclad |
| Amgen INC. | $759.03 | 2019-2025 | Uplizna, Aimovig |
| Lilly USA, LLC | $672.35 | 2020-2025 | Emgality, Amyvid, Reyvow |
| Ucb, INC. | $612.55 | 2019-2025 | Briviact, Rystiggo |
| Biogen, INC. | $598.84 | 2021-2025 | Tysabri, Vumerity, Skyclarys |
| Novartis Pharmaceuticals Corporation | $577.76 | 2019-2025 | |
| Genentech USA, INC. | $564.44 | 2021-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Axsome Therapeutics, INC. | $535.53 | 2023-2025 | Symbravo, Sunosi |
| Sk Life Science, INC. | $502.49 | 2020-2025 | |
| Upsher-Smith Laboratories LLC | $436.88 | 2021-2023 |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $363.77 | 2022-2025 | Nuplazid, Daybue |
| Biohaven Pharmaceutical Holding Company LTD. | $336.59 | 2022 | |
| Eisai INC. | $336.32 | 2022-2025 | |
| Celgene Corporation | $284.48 | 2023-2025 | Zeposia |
| Mdd US Operations, LLC | $253.46 | 2024 | Gocovri |
| Allergan, INC. | $244.63 | 2019-2022 | |
| Argenx US, INC. | $189.15 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Neurocrine Biosciences, INC. | $183.12 | 2022-2025 | Ingrezza, Ongentys |
| Biohaven Pharmaceuticals, INC. | $180.92 | 2021 | |
| Csl Behring | $150.01 | 2022-2025 | Hizentra |
| Tanabe Pharma America, INC. | $134.88 | 2021-2024 | |
| Neurelis, INC. | $130.98 | 2020-2025 | Valtoco |
| Abbott Laboratories | $126.94 | 2023-2024 | Infinity |
| Harmony Biosciences LLC | $123.15 | 2023-2025 | Wakix |
| Otsuka America Pharmaceutical, INC. | $122.99 | 2024-2025 | Rexulti, Nuedexta |
| Impel Pharmaceuticals LLC | $118.10 | 2024-2025 | Trudhesa |
| Takeda Pharmaceuticals U.S.A., INC. | $107.71 | 2022-2024 | Gammagard, Hyqvia |
| Genzyme Corporation | $100.41 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $91.82 | 2023-2024 | Ultomiris |
| Scilex Pharmaceuticals INC. | $90.53 | 2023-2025 | Ztlido |
| Boston Scientific Corporation | $86.17 | 2021-2023 | Vercise |
| Amneal Pharmaceuticals LLC | $74.52 | 2023-2025 | Crexont, Rytary, Lyvispah |
| Mallinckrodt Hospital Products INC. | $74.03 | 2023-2025 | Acthar |
| Merz Pharmaceuticals, LLC | $70.26 | 2021 | |
| Azurity Pharmaceuticals, INC. | $68.96 | 2023-2024 | Horizant, Horizant |
| Medtronic, INC. | $63.30 | 2022-2023 | Intellis Adaptivestim, Percept PC Brainsense |
| Avanir Pharmaceuticals, INC. | $54.11 | 2019-2021 | |
| Aquestive Therapeutics, INC. | $52.44 | 2021-2022 | |
| Kyowa Kirin, INC. | $44.60 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $43.36 | 2023 | Onpattro |
| Catalyst Pharmaceuticals, INC. | $36.87 | 2022 | |
| Ptc Therapeutics, INC. | $31.66 | 2020 | |
| Janssen Biotech, INC. | $31.58 | 2025 | |
| Springworks Therapeutics, INC. | $30.16 | 2025 | Gomekli |
| Grifols USA, LLC | $29.57 | 2022 | |
| Jazz Pharmaceuticals INC. | $27.30 | 2025 | |
| Horizon Therapeutics Plc | $27.03 | 2022-2023 | Uplizna |
| Averitas Pharma INC. | $26.55 | 2024 | Qutenza |
| Avion Pharmaceuticals | $22.89 | 2022 | |
| Cycle Pharmaceuticals INC | $22.83 | 2025 | Ormalvi |
| Alfasigma USA, INC. | $22.13 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $21.33 | 2024 | Zeposia |
| Supernus Pharmaceuticals, INC. | $20.50 | 2019 | |
| Nevro Corp. | $20.46 | 2023 | Senza |
| Tonix Medicines, INC. | $17.99 | 2025 | Zembrace Symtouch |
| Arbor Pharmaceuticals, INC. | $16.15 | 2022 | |
| Currax Pharmaceuticals LLC | $15.88 | 2023 | Nexletol, Onzetra Xsail, Nexlizet |
| Ge Healthcare | $14.52 | 2025 | |
| Janssen Pharmaceuticals, INC | $12.20 | 2022 | |
| Sunovion Pharmaceuticals INC. | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Francesconi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.